Trump Cuts mRNA Deal: Biosecurity Risk?
Former health officials are sounding the alarm: the decision to cut funding for mRNA vaccine progress by the Trump administration jeopardizes U.S. defenses against future pandemics, specifically bird flu. This move risks slowing down the development of vital mRNA vaccines, leaving the nation vulnerable to emerging threats. Experts highlight the critical role of mRNA technology in rapidly addressing mutating viruses. News Directory 3 looks at budget cuts, research funding reductions, and policy changes, all of which have weakened the nation’s biosecurity. Discover the biosecurity and the impact of these shifts in the fast-evolving landscape of scientific research.
Trump Vaccine Cuts Threaten Bird Flu Preparedness
Former health officials are raising alarms about the Trump governance’s decision to cancel $766 million in contracts for mRNA vaccine growth,warning it jeopardizes U.S. defenses against future pandemics.
“The administration’s actions are gutting our deterrence from biological threats,” said Beth Cameron, a senior adviser at Brown University’s Pandemic Center and former National Security Council director. She added that canceling the investment signals a shift in pandemic preparedness, which is detrimental to Americans.
The U.S. government began strengthening pandemic flu defenses during the George W.Bush administration, aiming to rapidly deploy vaccines domestically. Key to this strategy was ensuring vaccine safety and efficient distribution.
Experts say the Trump administration undermined these efforts by cutting health agency budgets,reducing research funding,and implementing policy changes. Staff reductions at the National Security Council and uncertainty surrounding the Biomedical Advanced Research and Development Authority (BARDA) further weakened the nation’s defenses. Peter Marks, the nation’s top vaccine adviser, resigned in March, citing an “unprecedented assault on scientific truth.”
Moast recently, the clawback of funds for mRNA vaccine development has increased the nation’s vulnerability.”When the need hits and we aren’t ready, no other country will come to our rescue and we will suffer greatly,” said Rick Luminous, an immunologist and former BARDA director.
The current bird flu virus, H5N1, poses a significant threat. Its spread among cattle in the U.S. last year raised concerns, as cows are biologically closer to humans than birds, suggesting the virus is adapting to human-like cells.
While the Biden administration funded Moderna to develop bird flu vaccines using mRNA technology, stipulating the U.S. government could purchase doses in advance of a pandemic,that agreement is now in jeopardy.
mRNA vaccines offer a faster development timeline compared to conventional methods that rely on biological processes like growing vaccine components in chicken eggs or cells. This speed is crucial, as flu viruses mutate rapidly, and vaccines are most effective when they match the circulating variant.
Bright said developing vaccines within eggs or cells can take 10 months after the genetic sequence of a variant is known. Relying on eggs also presents a risk, as a bird flu pandemic could decimate chicken populations, disrupting egg supplies.
The Trump administration also invested $500 million in older methods that rely on inactivated flu viruses, an approach largely abandoned in the 1980s after causing seizures in children. ”This politicized regression is baffling,” Bright said.
The Centers for Disease Control and Prevention’s dashboard indicates that only a handful of farmworkers have been tested for bird flu since March, despite their high risk of infection due to close contact with cattle and poultry.
“We’d need to instantly make vaccines,” said Angela Rasmussen, a virologist at the University of Saskatchewan in Canada.
The U.S. government could scale up production of existing bird flu vaccines developed in eggs or cells. Though, these vaccines target an older strain of H5N1, and their effectiveness against the current virus is uncertain.
Rasmussen also questioned the government’s ability to rapidly test and license updated shots, given staff reductions at HHS.proposed budget cuts could further undermine academic hospitals’ ability to conduct large clinical trials and reduce the number of health officials available in an emergency.
“You can’t just turn this all back on,” Rasmussen said. “The longer it takes to respond, the more people die.”
Achal Prabhala, a public health researcher in India, suggested other countries would likely produce bird flu vaccines first, possibly leaving the U.S. in a vulnerable position.
HHS communications director Andrew Nixon said the decision to halt investment in Moderna’s H5N1 mRNA vaccine was based on scientific and ethical concerns, citing “mounting evidence of adverse events associated with COVID-19 mRNA vaccines.”
however, numerous studies have found mRNA vaccines against COVID-19 to be safe.A placebo-controlled trial of over 30,000 people found adverse effects of Moderna’s vaccine were rare and transient.
Politicized mistrust in vaccines has grown, with a recent KFF poll showing that far more Republicans trust Robert F. Kennedy Jr. to provide reliable data on vaccines than their local health department or the CDC.
Rasmussen warned that should the bird flu become a pandemic in the next few years,”we will be screwed on multiple levels.”
Limited supplies could force the United States to compete with other countries for mRNA vaccines made abroad, potentially leading to a situation similar to the early days of the COVID-19 pandemic. “I fear we will once again see the kind of hunger games we saw in 2020,” cameron said.